US Stock MarketDetailed Quotes
ETNB 89bio
- 8.740
- +0.360+4.30%
Trading Nov 22 13:29 ET
1.03BMarket Cap-2952P/E (TTM)
8.910High8.300Low179.91KVolume8.420Open8.380Pre Close1.55MTurnover0.22%Turnover RatioLossP/E (Static)117.58MShares16.63052wk High2.72P/B702.92MFloat Cap7.00052wk Low--Dividend TTM80.43MShs Float47.253Historical High--Div YieldTTM7.28%Amplitude2.000Historical Low8.611Avg Price1Lot Size
89bio Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -378.77%-145.36M | -77.56%-61.16M | -32.03%-39.72M | -59.31%-129.19M | -26.56%-34.29M | -104.93%-30.36M | -132.20%-34.45M | -23.58%-30.09M | -5.61%-81.09M | 4.05%-27.1M |
| Net income from continuing operations | -329.30%-149.07M | -24.95%-47.97M | -79.22%-51.68M | -39.37%-142.19M | -63.54%-40.24M | -29.55%-34.73M | -53.24%-38.39M | -12.79%-28.84M | -13.21%-102.03M | 6.41%-24.6M |
| Operating gains losses | ---- | ---- | ---- | --1.21M | --0 | --0 | --0 | --1.21M | ---- | ---- |
| Depreciation and amortization | -20.00%8K | 20.00%12K | -35.71%9K | -23.08%50K | 6.67%16K | -37.50%10K | -37.50%10K | -22.22%14K | -17.72%65K | -28.57%15K |
| Deferred tax | ---- | ---- | ---- | --127K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non cash items | -13.17%244K | 63.80%457K | 29.62%337K | 16.83%1.1M | 30.66%277K | 17.57%281K | -4.45%279K | 32.65%260K | 52.19%939K | -5.78%212K |
| Change In working capital | -145.64%-822K | -2,532.19%-16.25M | 280.06%9.44M | -93.78%657K | 173.26%3.43M | -81.13%1.8M | -90.87%668K | -222.98%-5.24M | 224.60%10.56M | -7.31%-4.68M |
| -Change in prepaid assets | -211.71%-2.88M | -1,248.23%-16.41M | 145.42%2.09M | -307.78%-6.92M | -158.46%-3.68M | 258.55%2.58M | -158.09%-1.22M | -336.82%-4.6M | 158.73%3.33M | 8.24%-1.43M |
| -Change in payables and accrued expense | 406.67%2.25M | -80.90%368K | 1,300.00%7.22M | -46.56%3.96M | 207.22%3.37M | -108.86%-735K | -67.31%1.93M | 83.45%-602K | -16.98%7.41M | -11.97%-3.14M |
| -Change in other current liabilities | -366.67%-196K | -392.86%-207K | 407.32%126K | 2,066.85%3.62M | 8,806.98%3.74M | 6.67%-42K | 56.25%-42K | ---41K | ---184K | ---43K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -378.77%-145.36M | -77.56%-61.16M | -32.03%-39.72M | -59.31%-129.19M | -26.56%-34.29M | -104.93%-30.36M | -132.20%-34.45M | -23.58%-30.09M | -5.61%-81.09M | 4.05%-27.1M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -122.54%-8.64M | 127.35%27.85M | -2,045.88%-79.9M | -262.43%-123.02M | -475.38%-63.64M | 191.13%38.33M | -1,240.28%-101.81M | -84.66%4.11M | -574.13%-33.94M | -157.95%-11.06M |
| Net PPE purchase and sale | ---- | ---- | ---- | 42.86%-4K | ---- | ---- | ---- | ---- | 88.89%-7K | 92.59%-2K |
| Net investment purchase and sale | -122.54%-8.64M | 127.35%27.85M | -2,045.88%-79.9M | -262.49%-123.02M | -475.45%-63.64M | 191.13%38.33M | -1,240.11%-101.81M | -84.67%4.11M | -569.90%-33.94M | -157.86%-11.06M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -122.54%-8.64M | 127.35%27.85M | -2,045.88%-79.9M | -262.43%-123.02M | -475.38%-63.64M | 191.13%38.33M | -1,240.28%-101.81M | -84.66%4.11M | -574.13%-33.94M | -157.95%-11.06M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2,342.64%33.19M | -9.12%27.96M | -93.46%21.03M | 335.46%513.11M | 671.84%162.17M | -102.16%-1.48M | 9.25%30.77M | 1,109,051.72%321.65M | 393.62%117.83M | -4.02%21.01M |
| Net issuance payments of debt | --9.35M | --0 | --0 | --2.96M | --0 | --0 | --0 | --2.96M | --0 | --0 |
| Net common stock issuance | 88.09%-61K | -99.82%43K | -93.21%21.07M | 324.43%496.57M | 697.82%162.66M | -100.75%-512K | -14.22%24.18M | 1,069,689.66%310.24M | 2,998.44%117M | 439.94%20.39M |
| Proceeds from stock option exercised by employees | 3,843.88%24.81M | 322.33%27.82M | -79.20%1.9M | 1,300.88%15.86M | -162.95%-503K | 116.90%629K | 15,218.60%6.59M | --9.15M | 686.11%1.13M | 307.53%799K |
| Net other financing activities | 43.39%-904K | --98K | -179.80%-1.94M | -663.42%-2.28M | 108.52%15K | -2,913.21%-1.6M | --0 | ---693K | ---298K | ---176K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,342.64%33.19M | -9.12%27.96M | -93.46%21.03M | 335.46%513.11M | 671.84%162.17M | -102.16%-1.48M | 9.25%30.77M | 1,109,051.72%321.65M | 393.62%117.83M | -4.02%21.01M |
| Net cash flow | ||||||||||
| Beginning cash position | -13.54%212.22M | -38.00%217.57M | 472.19%316.16M | 5.33%55.26M | 247.96%251.93M | 304.73%245.44M | 539.05%350.93M | 5.33%55.26M | -46.59%52.46M | 82.28%72.4M |
| Current changes in cash | -1,962.87%-120.81M | 94.92%-5.36M | -133.34%-98.59M | 9,224.73%260.91M | 474.64%64.24M | -44.85%6.49M | -1,941.32%-105.49M | 11,933.98%295.68M | 106.12%2.8M | -234.62%-17.15M |
| End cash Position | -63.72%91.41M | -13.54%212.22M | -38.00%217.57M | 472.19%316.16M | 472.19%316.16M | 247.96%251.93M | 304.73%245.44M | 539.05%350.93M | 5.33%55.26M | 5.33%55.26M |
| Free cash flow | -378.77%-145.36M | -77.56%-61.16M | -32.03%-39.72M | -59.30%-129.19M | -26.57%-34.3M | -104.93%-30.36M | -132.22%-34.45M | -23.55%-30.09M | -5.53%-81.1M | 4.14%-27.1M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data